For more than 30 years we’ve been leading the drive to increase knowledge of the causes and best treatments of Crohn’s Disease and Ulcerative Colitis.
Our research strategy for 2022 – 2024 was created with input from a wide range of stakeholders. Thank you to everyone who took the time to share their views.
The strategy aims to drive change in areas that are most important to people affected by Inflammatory Bowel Disease (IBD), by focusing on three main domains:
- Directly funding research
- Increasing investment by others in IBD research
- Patient and public involvement